Sfoglia per AUTORE
SANT M
Collezione ASL Città di Torino

  

Items : 3

First-line imatinib vs second- and third-generation TKIs for chronic-phase CML: a systematic review and meta-analysis. in Blood advances / Blood Adv. 2020 Jun 23;4(12):2723-2735. doi: 10.1182/bloodadvances.2019001329.

2020
ASL Città di Torino

Sant M; Pravettoni G; Saglio G; Ferrero A; Ambrogi F; Banzi R; Vener C;

Erratum to "The histology of ovarian cancer: Worldwide distribution and implications for international survival comparisons (CONCORD-2)" [Gynecol. Oncol. 144 (2017) 405-413]. in Gynecologic oncology / Gynecol Oncol. 2017 Dec;147(3):726. doi: 10.1016/j.ygyno.2017.06.032. Epub 2017 Jul 5.

2017
ASL Biella
ASL Città di Torino

Gore M; Allemani C; Visser O; Chirlaque MD; Matz M; Sant M; Coleman MP;

Global surveillance of cancer survival 1995-2009: Analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2) in The Lancet

2015
ASL Città di Torino

Giles GG; Threlfall T; Currow D; Lewis C; Miles SA; Finan P; Sanz N; Wilkinson J; White C; Lawrence G; Brook C; Huws DW; Verne J; Murphy M; McPhail S; Brewster DH; Roche M; Black RJ; Linklater K; Morris E; Davies E; Greenberg D; Rashbass J; Meechan D; Poole J; Laue RI; Spitale A; Chiolero A; Konzelmann I; et alii...